Prescription Drug Dispensing Profiles for One Million Children: a Population-based Analysis

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 2012 Jul 14

PMID 22791273

Citations 21

Authors

Tingting Zhang

M Anne Smith

Pat G Camp

Salomah Shajari

Stuart M MacLeod

Bruce C Carleton

Affiliations

Soon will be listed here.

Abstract

Background: Population-based drug utilization databases that comprehensively capture an entire population's drug dispensing are scarce resources for epidemiological studies. This study aimed to examine the prescription-dispensing rates in children in British Columbia (BC) and describe the differences in the dispensing of medications in BC versus children in the United States (US) and Europe.

Methods: The study population was children aged 0-17 years in BC (n = 855,541). Children with at least one prescription dispensed in 2007 were identified using the provincial outpatient prescription dispensing database. All prescriptions were grouped on the basis of the Anatomical Therapeutic Chemical (ATC) classification system. Prevalence of drug dispensing was calculated in each age group, gender, and therapeutic class.

Results: Fifty-five percent of BC children were dispensed at least one prescription in 2007. Antibacterials for systemic use, dermatological corticosteroids, and drugs for obstructive airway diseases were commonly dispensed in each age group. The percentage of children who received psychoanaleptics was two to five times higher than rates reported in European countries, but 30% lower than rates reported in the US.

Conclusions: Half of the BC population <18 years received at least one prescription in 2007. Significant variations in drug dispensing were highlighted between BC, the US, and Europe. Future studies are needed to examine the outcomes of the prescribing in terms of benefit and harm. A variety of factors (e.g., disease prevalence rates, drug prescribing preferences) are likely to contribute to disparate dispensing of specific drug classes and should be principal factors in the investigation.

Citing Articles

Prescription drug use in Danish children and adolescents 2005-2023.

Kildegaard H, Olesen M, Henriksen T, Rasmussen L Eur J Epidemiol. 2024; 40(1):95-106.

PMID: 39661100 DOI: 10.1007/s10654-024-01186-6.

Understanding patient characteristics and medication prescriptions in children with mental health and neurodevelopmental disorders referred to a sleep clinic-A quality improvement/quality assurance analysis.

Ipsiroglu O, Bhathella J, Boldut R, Elbe D, Hill O, Keys E Front Psychiatry. 2022; 13:878356.

PMID: 36440388 PMC: 9684724. DOI: 10.3389/fpsyt.2022.878356.

From Prescription Drugs to Natural Health Products: Medication Use in Canadian Infants.

Bedard P, Winsor G, Garlock E, Azad M, Becker A, Mandhane P Children (Basel). 2022; 9(10).

PMID: 36291411 PMC: 9600175. DOI: 10.3390/children9101475.

The association between early life antibiotic exposure and the gut resistome of young children: a systematic review.

Lebeaux R, Karalis D, Lee J, Whitehouse H, Madan J, Karagas M Gut Microbes. 2022; 14(1):2120743.

PMID: 36289062 PMC: 9621065. DOI: 10.1080/19490976.2022.2120743.

Disruptive Behaviors and Intellectual Disability: Creating a New Script.

Chan M, Campbell M, Beyzaei N, Stockler S, Ipsiroglu O Front Psychiatry. 2022; 13:851490.

PMID: 35873258 PMC: 9304661. DOI: 10.3389/fpsyt.2022.851490.

References

Thrane N, Sorensen H . A one-year population-based study of drug prescriptions for Danish children. Acta Paediatr. 1999; 88(10):1131-6. DOI: 10.1080/08035259950168216. View

Son S, Kirchner J . Depression in children and adolescents. Am Fam Physician. 2000; 62(10):2297-308, 2311-2. View

Knellwolf A, Deligne J, Chiarotti F, Auleley G, Palmieri S, Boisgard C . Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol. 2007; 64(3):311-7. DOI: 10.1007/s00228-007-0401-6. View

Lecendreux M, Konofal E, Faraone S . Prevalence of attention deficit hyperactivity disorder and associated features among children in France. J Atten Disord. 2010; 15(6):516-24. DOI: 10.1177/1087054710372491. View

Lawvere S, Mahoney M . St. John's wort. Am Fam Physician. 2005; 72(11):2249-54. View

Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J . European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry. 2004; 13 Suppl 1:I7-30. DOI: 10.1007/s00787-004-1002-x. View

. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001; 108(4):1033-44. DOI: 10.1542/peds.108.4.1033. View

de Jong J, van den Berg P, De Vries T, de Jong-van den Berg L . Antibiotic drug use of children in the Netherlands from 1999 till 2005. Eur J Clin Pharmacol. 2008; 64(9):913-9. DOI: 10.1007/s00228-008-0479-5. View

Fegert J, Kolch M, Zito J, Glaeske G, Janhsen K . Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol. 2006; 16(1-2):197-206. DOI: 10.1089/cap.2006.16.197. View

10.

Mintzes B, Barer M, Kravitz R, Bassett K, Lexchin J, Kazanjian A . How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ. 2003; 169(5):405-12. PMC: 183290. View

11.

Dopfner M, Breuer D, Wille N, Erhart M, Ravens-Sieberer U . How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample--results of the BELLA study. Eur Child Adolesc Psychiatry. 2009; 17 Suppl 1:59-70. DOI: 10.1007/s00787-008-1007-y. View

12.

Palmer D, Bauchner H . Parents' and physicians' views on antibiotics. Pediatrics. 1997; 99(6):E6. DOI: 10.1542/peds.99.6.e6. View

13.

Hsia Y, Maclennan K . Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK. Eur J Epidemiol. 2009; 24(4):211-6. DOI: 10.1007/s10654-009-9321-3. View

14.

Clavenna A, Andretta M, Pilati P, Dusi M, Gangemi M, Gattoni M . Antidepressant and antipsychotic use in an Italian pediatric population. BMC Pediatr. 2011; 11:40. PMC: 3120679. DOI: 10.1186/1471-2431-11-40. View

15.

Clavenna A, Berti A, Gualandi L, Rossi E, De Rosa M, Bonati M . Drug utilisation profile in the Italian paediatric population. Eur J Pediatr. 2008; 168(2):173-80. DOI: 10.1007/s00431-008-0725-y. View

16.

Faber A, de Jong-van den Berg L, van den Berg P, Tobi H . Psychotropic co-medication among stimulant-treated children in The Netherlands. J Child Adolesc Psychopharmacol. 2005; 15(1):38-43. DOI: 10.1089/cap.2005.15.38. View

17.

Cazzato T, Pandolfini C, Campi R, Bonati M . Drug prescribing in out-patient children in Southern Italy. Eur J Clin Pharmacol. 2002; 57(8):611-6. DOI: 10.1007/s002280100356. View

18.

Schirm E, van den Berg P, Gebben H, Sauer P, de Jong-van den Berg L . Drug use of children in the community assessed through pharmacy dispensing data. Br J Clin Pharmacol. 2000; 50(5):473-8. PMC: 2014415. DOI: 10.1046/j.1365-2125.2000.00275.x. View

19.

Matthys J, De Meyere M, Van Driel M, De Sutter A . Differences among international pharyngitis guidelines: not just academic. Ann Fam Med. 2007; 5(5):436-43. PMC: 2000301. DOI: 10.1370/afm.741. View

20.

Huss M, Holling H, Kurth B, Schlack R . How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS). Eur Child Adolesc Psychiatry. 2009; 17 Suppl 1:52-8. DOI: 10.1007/s00787-008-1006-z. View